Patienter skal monitoreres nøje for at sikre, at der anvendes den lavest godkendte dosis Epoetin alfa til at opnå tilstrækkelig kontrol med symptomerne på anæmi.
Patients should be monitored closely to ensure that the lowest approved dose of Epoetin alfa is used to provide adequate control of the symptoms of anaemia.